Combination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma

PURPOSE: To evaluate whether the addition of two biological markers (MYC and BCL-2 protein overexpression) improves the stratification of high-risk patients with diffuse large B-cell lymphoma (DLBCL). METHOD: Seven risk factors were identified at diagnosis, and a maximum of 7 points were assigned to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Zhou, Min, Xu, Jing-Yan, Chen, Bing, Ouyang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583112/
https://www.ncbi.nlm.nih.gov/pubmed/26425100
http://dx.doi.org/10.2147/OTT.S86093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583112/
https://www.ncbi.nlm.nih.gov/pubmed/26425100
http://dx.doi.org/10.2147/OTT.S86093

Ejemplares similares